These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15743388)

  • 1. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
    Arias EB; Cartee GD
    Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
    Arias EB; Kim J; Cartee GD
    Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
    Zou L; Yang S; Hu S; Chaudry IH; Marchase RB; Chatham JC
    Shock; 2007 Apr; 27(4):402-8. PubMed ID: 17414423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
    Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
    Lee JE; Park JH; Moon PG; Baek MC
    Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics and PUGNAcity will overcome questioning of insulin resistance induction by nonselective inhibition of O-GlcNAcase.
    Dehennaut V; Lefebvre T
    Proteomics; 2013 Oct; 13(20):2944-6. PubMed ID: 23983178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calorie restriction increases muscle insulin action but not IRS-1-, IRS-2-, or phosphotyrosine-PI 3-kinase.
    Davidson RT; Arias EB; Cartee GD
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E270-6. PubMed ID: 11788357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats.
    Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
    Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.
    Mehdy A; Morelle W; Rosnoblet C; Legrand D; Lefebvre T; Duvet S; Foulquier F
    J Biochem; 2012 Apr; 151(4):439-46. PubMed ID: 22337894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro simulation of calorie restriction-induced decline in glucose and insulin leads to increased insulin-stimulated glucose transport in rat skeletal muscle.
    Arias EB; Cartee GD
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1782-8. PubMed ID: 17925453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and biological evaluation of some carbocyclic analogues of PUGNAc.
    Scaffidi A; Stubbs KA; Vocadlo DJ; Stick RV
    Carbohydr Res; 2008 Nov; 343(16):2744-53. PubMed ID: 18804755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase.
    Stubbs KA; Zhang N; Vocadlo DJ
    Org Biomol Chem; 2006 Mar; 4(5):839-45. PubMed ID: 16493467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of O-linked GlcNAc modification on the glucose response of ChREBP.
    Sakiyama H; Fujiwara N; Noguchi T; Eguchi H; Yoshihara D; Uyeda K; Suzuki K
    Biochem Biophys Res Commun; 2010 Nov; 402(4):784-9. PubMed ID: 21036147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle.
    Han DH; Chen MM; Holloszy JO
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1267-72. PubMed ID: 12954597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.